InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,704.96
(
-0.15%
)
US TECH 100
19,285.60
(
-0.25%
)
Dow Jones
42,086.75
(
0.15%
)
Brent Oil
74.25
(
-0.10%
)
Bitcoin
62,894.21
(
-0.09%
)
Post# of 26
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

leftope

Send PM Follow Ignore
Followers 1
Posts 23
Boards Moderated 0
Alias Born 02/22/2011

leftope

Re: triadtreats post# 1

Wednesday, 08/21/2013 12:21:50 AM

Wednesday, August 21, 2013 12:21:50 AM

Post# of 26
Agreed it looks interesting.

Management owns significant stakes, much of which is in restricted shares with ROC and growth targets attached.

Has $3.2mm in NOLs as of 4/30, compared to $1.05mm in TTM operating income.

Largest customer is 49% of sales. It has little differentiation in its products from competitors.

The good news is things are looking optimistic for next year. Backlog is $12.6mm vs last year's $9.8mm. The stock may not have discounted the anticipated FY14 earnings, but I don't see any visibility beyond immediate backlog, do you?



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up